Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Dec;63(12):1576–1580. doi: 10.1136/ard.2003.016253

Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density

M Lodder 1, Z de Jong 1, P Kostense 1, E Molenaar 1, K Staal 1, A Voskuyl 1, J Hazes 1, B Dijkmans 1, W Lems 1
PMCID: PMC1754831  PMID: 15547081

Abstract

Objective: To examine variables associated with bone mineral density (BMD) in patients with rheumatoid arthritis (RA).

Methods: We investigated 373 patients with low to moderately active RA. Patients with low disease activity were recruited from a cohort of patients in clinical remission. Patients with moderately active disease were included in a trial comparing the effects of long term high intensity exercise programme and conventional physical therapy. Demographic and clinical data were collected. Bone mineral density (BMD) was measured by means of dual x ray absorptiometry (DXA). Associations between demographic and clinical measurements on the one hand and BMD on the other were investigated in regression analyses.

Results: The patient group consisted of middle aged, mainly female, patients. The median (interquartile range) disease duration was 7 (4 to 13) years, the mean disease activity score (standard deviation) was 3.2 (1.4). Of the group, 66% was rheumatoid factor positive, and 83% (n = 304) had never used corticosteroids. The median Larsen score of hands and feet was 27 (5 to 61). Greater age and low body mass index were related to low BMD at the hip and spine. High Larsen score for hands and feet was significantly associated with low BMD at the hip. The use of corticosteroids was not independently associated with BMD. The results of the multiple regression analyses also applied to the subgroup of corticosteroid naive patients.

Conclusion: BMD data of patients with low to moderately active RA demonstrated an association between high radiological RA damage and low BMD at the hip, which suggests an association between the severity of RA and the risk of generalised bone loss, which also occurred in corticosteroid naive patients.

Full Text

The Full Text of this article is available as a PDF (76.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995 Jan;54(1):49–52. doi: 10.1136/ard.54.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Deodhar A. A., Woolf A. D. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol. 1996 Apr;35(4):309–322. doi: 10.1093/rheumatology/35.4.309. [DOI] [PubMed] [Google Scholar]
  4. Dykman T. R., Gluck O. S., Murphy W. A., Hahn T. J., Hahn B. H. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1985 Apr;28(4):361–368. doi: 10.1002/art.1780280402. [DOI] [PubMed] [Google Scholar]
  5. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  6. Genant H. K., Cooper C., Poor G., Reid I., Ehrlich G., Kanis J., Nordin B. E., Barrett-Connor E., Black D., Bonjour J. P. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10(4):259–264. doi: 10.1007/s001980050224. [DOI] [PubMed] [Google Scholar]
  7. Gough A. K., Lilley J., Eyre S., Holder R. L., Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994 Jul 2;344(8914):23–27. doi: 10.1016/s0140-6736(94)91049-9. [DOI] [PubMed] [Google Scholar]
  8. Hall G. M., Spector T. D., Griffin A. J., Jawad A. S., Hall M. L., Doyle D. V. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum. 1993 Nov;36(11):1510–1516. doi: 10.1002/art.1780361105. [DOI] [PubMed] [Google Scholar]
  9. Haugeberg G., Uhlig T., Falch J. A., Halse J. I., Kvien T. K. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000 Mar;43(3):522–530. doi: 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  10. Haugeberg G., Uhlig T., Falch J. A., Halse J. I., Kvien T. K. Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum. 2000 Dec;43(12):2776–2784. doi: 10.1002/1529-0131(200012)43:12<2776::AID-ANR18>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  11. Hochberg M. C., Chang R. W., Dwosh I., Lindsey S., Pincus T., Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992 May;35(5):498–502. doi: 10.1002/art.1780350502. [DOI] [PubMed] [Google Scholar]
  12. Huusko T. M., Korpela M., Karppi P., Avikainen V., Kautiainen H., Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis. 2001 May;60(5):521–522. doi: 10.1136/ard.60.5.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kanis J. A., Melton L. J., 3rd, Christiansen C., Johnston C. C., Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994 Aug;9(8):1137–1141. doi: 10.1002/jbmr.5650090802. [DOI] [PubMed] [Google Scholar]
  14. Kroot E. J., Nieuwenhuizen M. G., de Waal Malefijt M. C., van Riel P. L., Pasker-de Jong P. C., Laan R. F. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum. 2001 Jun;44(6):1254–1260. doi: 10.1002/1529-0131(200106)44:6<1254::AID-ART216>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  15. Kröger H., Honkanen R., Saarikoski S., Alhava E. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study. Ann Rheum Dis. 1994 Jan;53(1):18–23. doi: 10.1136/ard.53.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Laan R. F., Buijs W. C., Verbeek A. L., Draad M. P., Corstens F. H., van de Putte L. B., van Riel P. L. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis. 1993 Jan;52(1):21–26. doi: 10.1136/ard.52.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Laan R. F., van Riel P. L., van Erning L. J., Lemmens J. A., Ruijs S. H., van de Putte L. B. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol. 1992 Feb;31(2):91–96. doi: 10.1093/rheumatology/31.2.91. [DOI] [PubMed] [Google Scholar]
  18. Lems W. F., Dijkmans B. A. Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis. 1998 Jun;57(6):325–327. doi: 10.1136/ard.57.6.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lodder Mariette C., Haugeberg Glenn, Lems Willem F., Uhlig Till, Orstavik Ragnhild E., Kostense Piet J., Dijkmans Ben A. C., Kvien Tore K., Woolf Anthony D., Oslo-Truro-Amsterdam (OSTRA) Collaborative Study Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum. 2003 Apr 15;49(2):209–215. doi: 10.1002/art.10996. [DOI] [PubMed] [Google Scholar]
  20. Martin J. C., Munro R., Campbell M. K., Reid D. M. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol. 1997 Jan;36(1):43–49. doi: 10.1093/rheumatology/36.1.43. [DOI] [PubMed] [Google Scholar]
  21. Molenaar Esmeralda T. H., Voskuyl Alexandre E., Dijkmans Ben A. C. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. J Rheumatol. 2002 Feb;29(2):267–270. [PubMed] [Google Scholar]
  22. Sambrook P. N., Eisman J. A., Champion G. D., Yeates M. G., Pocock N. A., Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum. 1987 Jul;30(7):721–728. doi: 10.1002/art.1780300701. [DOI] [PubMed] [Google Scholar]
  23. Sambrook P. N., Spector T. D., Seeman E., Bellamy N., Buchanan R. R., Duffy D. L., Martin N. G., Prince R., Owen E., Silman A. J. Osteoporosis in rheumatoid arthritis. A monozygotic co-twin control study. Arthritis Rheum. 1995 Jun;38(6):806–809. doi: 10.1002/art.1780380614. [DOI] [PubMed] [Google Scholar]
  24. Sambrook P., Raj A., Hunter D., Naganathan V., Mason R., Robinson B. Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. J Rheumatol. 2001 May;28(5):1063–1067. [PubMed] [Google Scholar]
  25. Scott D. L., Houssien D. A., Laasonen L. Proposed modification to Larsen's scoring methods for hand and wrist radiographs. Br J Rheumatol. 1995 Jan;34(1):56–56. doi: 10.1093/rheumatology/34.1.56. [DOI] [PubMed] [Google Scholar]
  26. Spector T. D., Hall G. M., McCloskey E. V., Kanis J. A. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ. 1993 Feb 27;306(6877):558–558. doi: 10.1136/bmj.306.6877.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. ten Wolde S., Breedveld F. C., Hermans J., Vandenbroucke J. P., van de Laar M. A., Markusse H. M., Janssen M., van den Brink H. R., Dijkmans B. A. Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet. 1996 Feb 10;347(8998):347–352. doi: 10.1016/s0140-6736(96)90535-8. [DOI] [PubMed] [Google Scholar]
  28. van der Heijde D. M., van 't Hof M., van Riel P. L., van de Putte L. B. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993 Mar;20(3):579–581. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES